Page 12 - Ano Caps News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Talon Metals reports nickel-copper mineralization in more than 60 holes outside of Tamarack resource area The resource company told shareholders that drilling is progressing “extremely well” at the nickel project, with consistent intersections at shallow depths in the CGO East and CGO Bend areas New drill holes show that the CGO East area has continuous nickel-copper mineralization over a strike length of more than 500 metres Talon Metals Corp (TSE:TLO) (OTCMKTS:TLOFF) (FRA:TAO) has intersected nickel-copper mineralization in over 60 holes outside the current resource area at ...

LexaGene looks to take a big step forward starting the process to uplist to the Nasdaq Exchange LexaGene Holdings (CVE: LXG – OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to share news the company is taking steps to list its common shares on the Nasdaq Capital Market with the goal of submitting its application prior to the end of 2021. Regan shares with Proactive why the company is making the move and he also talks about some of the steps the company has already taken. Quick facts: LexaGene Holdings Inc. Follow

Arizona Silver Exploration drilling has begun on Perry Claim at Philadelphia Gold/Silver Property Arizona Silver Exploration (CVE: AZS – OTCQB: AZASF) CEO Mike Stark joined Steve Darling from Proactive to share news the company has begun drilling again at their Philadelphia Project in Arizona. Stark telling Proactive the drill rig is on-site and has completed 3 holes already on the recently acquired Perry Claim. The company is planning 15 holes total. Stark adding they are exploring with some drill testing along strike of the 1,250 feet of visible vein outcropping at surface. Quick facts: A...

Aequus Pharmaceuticals first quarter results show good progress in spite of the coronavirus pandemic Doug Janzen, Aequus chairman and CEO said: "We were pleased to see sales meet internal forecasts since February and we expect to continue our revenue growth trajectory going forward" On March 1, 2021, Aequus Pharmaceuticals announced the commercial availability of its Evolve preservative-free lubricating eye drops for dry eye care Aequus Pharmaceuticals Inc. (CVE:AQS) (OTCQB:AQSZF) has reported its financial results for the first quarter ended March 31, 2021, showing good progres...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires